Edwards Lifesciences Corp Operating Cash Flow 2008-2026 | EW
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is Edwards Lifesciences Corp's current operating cash flow?
Edwards Lifesciences Corp (EW) annual operating cash flow for 2025 was $1.60B, a 194.15% increase from 2024. Edwards Lifesciences Corp operating cash flow for the quarter ending March 31, 2026 was $43.8M.
What was Edwards Lifesciences Corp's operating cash flow in 2024?
Edwards Lifesciences Corp annual operating cash flow for 2024 was $542.3M, a 39.46% decline from 2023.
What was Edwards Lifesciences Corp's operating cash flow in 2023?
Edwards Lifesciences Corp annual operating cash flow for 2023 was $895.8M, a 26.47% decline from 2022.
What is Edwards Lifesciences Corp's 5-year operating cash flow CAGR?
Edwards Lifesciences Corp operating cash flow grew at a compound annual growth rate (CAGR) of 8.64% from FY2020 to FY2025, going from $1.05B to $1.60B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.60B | +194.2% | 10-K |
| FY2024 | $542.3M | -39.5% | 10-K |
| FY2023 | $895.8M | -26.5% | 10-K |
| FY2022 | $1.22B | -29.7% | 10-K |
| FY2021 | $1.73B | +64.3% | 10-K |
| FY2020 | $1.05B | -10.9% | 10-K |
| FY2019 | $1.18B | +27.6% | 10-K |
| FY2018 | $926.7M | -7.4% | 10-K |
| FY2017 | $1.00B | +42.1% | 10-K |
| FY2016 | $704.4M | +28.1% | 10-K |
| FY2015 | $549.7M | -46.2% | 10-K |
| FY2014 | $1.02B | +116.3% | 10-K |
| FY2013 | $472.7M | +30.5% | 10-K |
| FY2012 | $362.1M | +17.5% | 10-K |
| FY2011 | $308.2M | +22.6% | 10-K |
| FY2010 | $251.4M | +52.1% | 10-K |
| FY2009 | $165.3M | +7.9% | 10-K |
| FY2008 | $153.2M | - | 10-K |